Metraipolis › archive › dc_de4d397b5679
Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy — Europe PMC PMID:40956616
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40956616
- DOI
- 10.1172/jci193956
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:22:29.476Z
- SHA-256 of the archived text
2c49129cca491b7fd1b5942de70d883f54066213ef8c0a71a5bfc0342787d8db- Stable URL of this page
https://metraipolis.com/documento/dc_de4d397b5679
How to cite
Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy — Europe PMC PMID:40956616 — Europe PMC (en), https://europepmc.org/article/MED/40956616 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de4d397b5679 (Metraipolis archive dc_de4d397b5679, sha256 2c49129cca491b7fd1b5942de70d883f54066213ef8c0a71a5bfc0342787d8db)
BibTeX
@misc{dcde4d397b5679,
title = {Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy — Europe PMC PMID:40956616},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40956616},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de4d397b5679; sha256 2c49129cca491b7fd1b5942de70d883f54066213ef8c0a71a5bfc0342787d8db},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40956616. Agents can read the archived copy with the MCP tool read_document.